Barclays
INVA icon

Barclays’s Innoviva INVA Stock Holding History

Barclays’s Portfolio INVA Stock Details INVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-100
Closed -$2K – 7155
2018
Q4 		$2K Sell
100
-300
-75% -$4.87K ﹤0.01% 6719
2018
Q3 		$6K Buy
400
+300
+300% +$4.32K ﹤0.01% 6755
2018
Q2 		$1K Hold
100
– – ﹤0.01% 6884
2018
Q1 		$2K Hold
100
– – ﹤0.01% 6902
2017
Q4 		$1K Sell
100
-200
-67% -$2.67K ﹤0.01% 6842
2017
Q3 		$4K Sell
300
-100
-25% -$1.32K ﹤0.01% 6481
2017
Q2 		$5K Sell
400
-400
-50% -$5.02K ﹤0.01% 6233
2017
Q1 		$11K Sell
800
-1,000
-56% -$11.8K ﹤0.01% 6045
2016
Q4 		$19K Buy
1,800
+100
+6% +$1.05K ﹤0.01% 5649
2016
Q3 		$19K Sell
1,700
-1,000
-37% -$11.7K ﹤0.01% 5495
2016
Q2 		$28K Sell
2,700
-32,500
-92% -$385K ﹤0.01% 5132
2016
Q1 		$422K Buy
35,200
+34,600
+5,767% +$380K ﹤0.01% 3286
2015
Q4 		$6K Sell
600
-4,000
-87% -$36.8K ﹤0.01% 5524
2015
Q3 		$32K Hold
4,600
– – ﹤0.01% 5248
2015
Q2 		$83K Buy
4,600
+3,600
+360% +$61.8K ﹤0.01% 4794
2015
Q1 		$15K Sell
1,000
-4,200
-81% -$63.6K ﹤0.01% 5989
2014
Q4 		$73K Sell
5,200
-12,300
-70% -$185K ﹤0.01% 5431
2014
Q3 		$297K Buy
17,500
+8,000
+84% +$184K ﹤0.01% 4403
2014
Q2 		$276K Sell
9,500
-11,845
-55% -$284K ﹤0.01% 4510
2014
Q1 		$516K Buy
21,345
+3,102
+17% +$90.8K ﹤0.01% 3932
2013
Q4 		$515K Sell
18,243
-62,546
-77% -$1.83M ﹤0.01% 4062
2013
Q3 		$2.6M Sell
80,789
-11,914
-13% -$370K ﹤0.01% 2290
2013
Q2 		$2.88M Buy
+92,703
New +$2.49M ﹤0.01% 2133

Other funds holding INVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Barclays's INVA Position: Q1 2026 in Review

Barclays reduced its Innoviva (INVA) stake by 27% in Q1 2026, selling an estimated $3.4M and leaving 430,879 shares worth $10M. The position accounts for ﹤0.01% of the portfolio, ranked #1450.

Barclays first reported a position in INVA in Q2 2013 and has held it in 52 quarters since. The position peaked at $11.8M in Q4 2025. 286 funds tracked by Wall St. Rank hold INVA as of Q1 2026.

  • Barclays held 430,879 shares of Innoviva worth $10M as of Q1 2026.
  • Barclays sold 157,650 Innoviva shares in Q1 2026, an estimated $3.4M.
  • Innoviva made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #1450 holding.
  • Barclays first reported a position in Innoviva in Q2 2013 and has held it in 52 quarters since.
  • Barclays's Innoviva position peaked at $11.8M in Q4 2025.
  • 286 funds tracked by Wall St. Rank held Innoviva as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.